Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Daniele

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Journal of Clinical Gastroenterology|February 19, 2008
Insights in gastric carcinogenesis from Helicobacter pylori infectionBruno Daniele
Hepatobiliary Surgery and Nutrition|September 10, 2014
TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesisDomenico Germano, Bruno Daniele
Clinics in Liver Disease|April 16, 2005
Staging for liver cancerBruno Daniele, Francesco Perrone
World Journal of Gastroenterology|April 4, 2014
Systemic therapy of hepatocellular carcinoma: current status and future perspectivesDomenico Germano, Bruno Daniele
Journal of Clinical Gastroenterology|July 1, 2009
Target therapy for hepatocellular carcinoma: is sorafenib for everybody?Bruno Daniele, Massimo Di Maio
Recenti Progressi in Medicina|August 5, 2005
[Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography]Emiddio Barletta, Vincenza Tinessa, Bruno Daniele
The New England Journal of Medicine|February 22, 2002
Chemotherapy in the elderlyFrancesco Perrone, Ciro Gallo, Bruno Daniele
Nature Reviews. Clinical Oncology|August 27, 2009
Targeted therapies: Role of sorafenib in HCC patients with compromised liver functionMassimo Di Maio, Bruno Daniele, Francesco Perrone
Journal of the National Cancer Institute|October 30, 2008
Re: Design and endpoints of clinical trials in hepatocellular carcinomaMassimo Di Maio, Bruno Daniele, Ciro Gallo, et al.
Journal of Clinical Gastroenterology|September 25, 2003
Cyclo-oxygenase inhibition in colorectal adenomas and cancerPaolo Ricchi, Sandro Pignata, Rosario Vincenzo Iaffaioli, et al.
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Journal of Clinical Gastroenterology|February 19, 2008
Insights in gastric carcinogenesis from Helicobacter pylori infectionBruno Daniele
Hepatobiliary Surgery and Nutrition|September 10, 2014
TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesisDomenico Germano, Bruno Daniele
Clinics in Liver Disease|April 16, 2005
Staging for liver cancerBruno Daniele, Francesco Perrone
World Journal of Gastroenterology|April 4, 2014
Systemic therapy of hepatocellular carcinoma: current status and future perspectivesDomenico Germano, Bruno Daniele
Journal of Clinical Gastroenterology|July 1, 2009
Target therapy for hepatocellular carcinoma: is sorafenib for everybody?Bruno Daniele, Massimo Di Maio
Recenti Progressi in Medicina|August 5, 2005
[Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography]Emiddio Barletta, Vincenza Tinessa, Bruno Daniele
The New England Journal of Medicine|February 22, 2002
Chemotherapy in the elderlyFrancesco Perrone, Ciro Gallo, Bruno Daniele
Nature Reviews. Clinical Oncology|August 27, 2009
Targeted therapies: Role of sorafenib in HCC patients with compromised liver functionMassimo Di Maio, Bruno Daniele, Francesco Perrone
Journal of the National Cancer Institute|October 30, 2008
Re: Design and endpoints of clinical trials in hepatocellular carcinomaMassimo Di Maio, Bruno Daniele, Ciro Gallo, et al.
Journal of Clinical Gastroenterology|September 25, 2003
Cyclo-oxygenase inhibition in colorectal adenomas and cancerPaolo Ricchi, Sandro Pignata, Rosario Vincenzo Iaffaioli, et al.
Pageof 15